2,3,4,5-Tetrafluorophenol, 97%

Name: 2,3,4,5-Tetrafluorophenol, 97% | 3467-85-4
Brand: J&K Chemical
SKU: JK2323907_1_G
Price: 244.8 USD
Availability: OutOfStock

Cat. No JK2323907_1_G

Vendor: J&K Chemical

Product Information

Product Name

2,3,4,5-Tetrafluorophenol, 97%

Brand Name

J&K

Product Number

2323907

CAS

3467-85-4

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

15631663

IUPAC Name

2,3,4,5-tetrafluorophenol

InChI Key

QXYLYYZZWZQACI-UHFFFAOYSA-N

SMILES

C1=C(C(=C(C(=C1F)F)F)F)O

References Data Source From Pubchem

Preclinical characterization of 3p-C-DEPA-NCS and 3p-C-DEPA-TFP-PEG4 as potential Actinium-225 bifunctional chelators using DOTA-NCS and macropa-NCS as benchmarks

Publication Name: EJNMMI Radiopharmacy and Chemistry

Publication Date: 2025-12-22

DOI: 10.1186/s41181-025-00408-w

Bioconjugation Methods for Radiopharmaceutical Chemistry

Publication Name: Radiopharmaceutical Chemistry

Publication Date: 2019

DOI: 10.1007/978-3-319-98947-1_25

Production, applications and status of zirconium-89 immunoPET agents

Publication Name: Journal of Radioanalytical and Nuclear Chemistry

Publication Date: 2017-08-24

DOI: 10.1007/s10967-017-5358-z

Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models

Publication Name: EJNMMI Research

Publication Date: 2016-05-04

DOI: 10.1186/s13550-016-0195-6

Radiolabeled Antibodies for Cancer Imaging and Therapy

Publication Name: Methods in molecular biology (Clifton, N.J.)

Publication Date: 2012

DOI: 10.1007/978-1-61779-974-7_38

2,3,4,5-Tetrafluorophenol, 97%

Product Information

General Information

References Data Source From Pubchem

Preclinical characterization of 3p-C-DEPA-NCS and 3p-C-DEPA-TFP-PEG4 as potential Actinium-225 bifunctional chelators using DOTA-NCS and macropa-NCS as benchmarks

Bioconjugation Methods for Radiopharmaceutical Chemistry

Production, applications and status of zirconium-89 immunoPET agents

Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models

Radiolabeled Antibodies for Cancer Imaging and Therapy